Year 2020 Vol. 28 No 4




Ryazan State Medical University, Ryazan,
The Russian Federation

Apoptosis is a model of genetically programmed cell death and the main mechanism that allows to remove the unwanted, old or damaged cells. In both physiological and pathophysiological conditions, various factors, including mechanical forces, reactive oxygen and nitrogen forms, cytokines, oxidized lipoproteins can affect vascular cell apoptosis. The signaling pathway of Fas / Fas- ligand / caspase death, the Bcl-2 / mitochondria family of proteins, the p53 tumor suppression gene, and the c-myc protooncogene can be activated in atherosclerotic lesions and mediate cell death during the development of atherosclerosis. Abnormal expression apoptosis-regulating genes and their dysfunction can weaken or accelerate apoptosis of vascular cells and affect the integrity and stability of atherosclerotic plaques. Further findings of the mechanism that regulates apoptosis can help develop a new treatment strategy for atherosclerosis and its main complication, restenosis of the reconstruction zone. At present, the role of apoptosis indicators in the development of atherosclerosis and its main complications remains unclear. Further study of this problem is required for a deeper understanding of atherosclerosis pathogenesis and restenosis of the reconstruction zone and the development of effective treatment methods.

Keywords: apoptosis, restenosis, atherosclerosis, Bcl-2 proteins, caspases
p. 418-427 of the original issue
  1. Papojan SA, Shhegolev AA, Radchenko AN, Gromov DG, Mutaev MM, Sazonov MJu, Ishevskij AG. Otdalennye rezultaty jendovaskuljarnogo lechenija porazhenij poverhnostnoj bedrennoj arterii tipov S i D po klassifikacii TASC II. Angiologija i Sosud Hirurgija. 2018;24(1):73-77. ( In Russ.)
  2. Roh JW, Ko YG, Ahn CM, Hong SJ, Shin DH, Kim JS, Kim BK, Choi D, Hong MK, Jang Y. Risk factors for restenosis after drug-coated balloon angioplasty for complex femoropopliteal arterial occlusive disease. Ann Vasc Surg. 2019 Feb;55:45-54. doi: 10.1016/j.avsg.2018.06.015
  3. Zhou Y, Zhang Z, Lin S, Xiao J, Ai W, Wang J, Li Y, Li Q. Comparative Effectiveness of endovascular treatment modalities for de novo femoropopliteal lesions: a network meta-analysis of randomized controlled trials. J Endovasc Ther. 2020;27(1):42-59. doi: 10.1177/1526602819895996
  4. Choe N, Kwon DH, Shin S, Kim YS, Kim YK, Kim J, Ahn Y, Eom GH, Kook H. The microRNA miR-124 inhibits vascular smooth muscle cell proliferation by targeting S100 calcium-binding protein A4 (S100A4). FEBS Lett. 2017 Apr;591(7):1041-52. doi: 10.1002/1873-3468.12606
  5. Havinson VH, Linkova NS, Dudkov AV, Djatlova AS. Molekuljarnye markery kaspaza-zavisimogo i mitohondrialnogo apoptoza: rol v razvitii patologii i v processah kletochnogo starenija. Uspehi Sovrem Biologii. 2018;138(2):126-37. doi: 10.7868/S0042132418020023 ( In Russ.)
  6. Grigorev MJu, Imjanitov EN, Hanson KP. Apoptoz v norme i patologii. Med Akad Zhurn. 2003;3(3):3-11. ( In Russ.)
  7. Varga OYu, Ryabkov VA. Apoptosis: concept. mechanisms of realization. Significance. Jekologija Cheloveka. 2006;(7):28-32. ( In Russ.)
  8. Wang X, Guo Z, Ding Z, Mehta JL. Inflammation, Autophagy, and Apoptosis After Myocardial Infarction. J Am Heart Assoc. 2018 Apr 21;7(9). pii: e008024. doi: 10.1161/JAHA.117.008024
  9. Hockings C, Alsop AE, Fennell SC, Lee EF, Fairlie WD, Dewson G, Kluck RM. Mcl-1 and Bcl-xL sequestration of Bak confers differential resistance to BH3-only proteins. Cell Death Differ. 2018 Mar;25(4):721-34. doi: 10.1038/s41418-017-0010-6
  10. Alzate JM, Montoya-Florez LM, Pérez JE, Rocha NS, Pedraza-Ordonez FJ. The role of the multi-drug resistance 1, p53, b cell lymphoma 2, and bcl 2-associated X genes in the biologic behavior and chemotherapeutic resistance of canine transmissible venereal tumors. Vet Clin Pathol. 2019 Dec;48(4):730-39. doi: 10.1111/vcp.12805
  11. Ryzjov SV, Novikov VV. Molecular mechanisms of apoptotic process. Ros Bioterapevt Zhurn. 2002;1(1):27-33. (In Russ.)
  12. Weber A, Paschen SA, Heger K, Wilfling F, Frankenberg T, Bauerschmitt H, Seiffert BM, Kirschnek S, Wagner H, Häcker G. BimS-induced apoptosis requires mitochondrial localization but not interaction with anti-apoptotic Bcl-2 proteins. J Cell Biol. 2007 May 21;177(4):625-36. doi: 10.1083/jcb.200610148
  13. Kutuk O, Basaga H. Bcl-2 protein family: implications in vascular apoptosis and atherosclerosis. Apoptosis. 2006 Oct;11(10):1661-75. doi: 10.1007/s10495-006-9402-7
  14. Fitzgerald TN, Shepherd BR, Asada H, Teso D, Muto A, Fancher T, Pimiento JM, Maloney SP, Dardik A. Laminar shear stress stimulates vascular smooth muscle cell apoptosis via the Akt pathway. J Cell Physiol. 2008 Aug;216(2):389-95. doi: 10.1002/jcp.21404
  15. Choi BM, Pae HO, Jang SI, Kim YM, Chung HT. Nitric oxide as a pro-apoptotic as well as anti-apoptotic modulator. J Biochem Mol Biol. 2002;35(1):116126. doi: 10.5483/bmbrep.2002.35.1.116
  16. Chae IH, Park KW, Kim HS, Oh BH. Nitric oxide-induced apoptosis is mediated by Bax/Bcl-2 gene expression, transition of cytochrome c, and activation of caspase-3 in rat vascular smooth muscle cells. Clin Chim Acta. 2004 Mar;341(1-2):83-91. doi: 10.1016/j.cccn.2003.11.009
  17. Kockx MM, Knaapen MW. The role of apoptosis in vascular disease. J Pathol. 2000 Feb;190(3):267-80. doi: 10.1002/(SICI)1096-9896(200002)190:3<267::AID-PATH523>3.0.CO;2-A
  18. Saxena A, McMeekin JD, Thomson DJ. Expression of Bcl-x, Bcl-2, Bax, and Bak in endarterectomy and atherectomy specimens. J Pathol. 2002 Mar;196(3):335-42. doi: 10.1002/path.1040
  19. Chen F, Eriksson P, Kimura T, Herzfeld I, Valen G. Apoptosis and angiogenesis are induced in the unstable coronary atherosclerotic plaque. Coron Artery Dis. 2005 May;16(3):191-97. doi: 10.1097/00019501-200505000-00009
  20. Vladimirskaya TE, Shved IA, Demidchik YE. Ratio of expression of the Bcl-2 and Bax proteins in the atherosclerotic coronary artery wall. Proceedings of the National Academy of Sciences of Belarus, Medical series. 2015;(4):51-55. (In Russ.)
  21. Miyashita T, Harigai M, Hanada M, Reed JC. Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res. 1994 Jun 15;54(12):3131-35.
  22. Speir E, Modali R, Huang ES, Leon MB, Shawl F, Finkel T, Epstein SE. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science. 1994 Jul 15;265(5170):391-94. doi: 10.1126/science.8023160
  23. Bennett MR, Evan GI, Schwartz SM. Apoptosis of rat vascular smooth muscle cells is regulated by p53-dependent and independent pathways. Circ Res.1995;77(2):266-73. doi: 10.1161/01.res.77.2.266
  24. Jacob T, Hingorani A, Ascher E. p53 gene therapy modulates signal transduction in the apoptotic and cell cycle pathways downregulating neointimal hyperplasia. Vasc Endovascular Surg. 2012 Jan;46(1):45-53. doi: 10.1177/1538574411422277
  25. Fanidi A, Harrington E, Evan G. Cooperative interaction between c -myc and bcl-2 proto-oncogenes. Nature.1992; 359:554-556. doi: 10.1038/359554a0
  26. De Feo M, Forte A, Onorati F, Renzulli A, Cipollaro M, Cotrufo M, Rossi F, Cascino A. Rat carotid arteriotomy: c-myc is involved in negative remodelling and apoptosis. J Cardiovasc Med (Hagerstown). 2006 Jan;7(1):61-67. doi: 10.2459/01.JCM.0000199779.92967.59
  27. Farrell KA, Withers SB, Holt CM. C-Myb function in the vessel wall. Front Biosci (Elite Ed). 2011 Jun 1;3:968-77. doi: 10.2741/e302
  28. Zhu ZR, He Q, Wu WB, Chang GQ, Yao C, Zhao Y, Wang M, Wang SM. MiR-140-3p is Involved in In-Stent Restenosis by Targeting C-Myb and BCL-2 in Peripheral Artery Disease. J Atheroscler Thromb. 2018 Nov 1;25(11):1168-1181. doi: 10.5551/jat.44024
  29. Lambert DL, Malik N, Shepherd L, Gunn J, Francis SE, King A, Crossman DC, Cumberland DC, Holt CM. Localization of c-Myb and induction of apoptosis by antisense oligonucleotide c-Myb after angioplasty of porcine coronary arteries. Arterioscler Thromb Vasc Biol. 2001 Nov;21(11):1727-32. doi: 10.1161/hq1101.098552
  30. Simons M, Edelman ER, DeKeyser JL, Langer R, Rosenberg RD. Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo. Nature. 1992 Sep 3;359(6390):67-70. doi: 10.1038/359067a0
  31. Guo X, Chen KH, Guo Y, Liao H, Tang J, Xiao RP. Mitofusin 2 triggers vascular smooth muscle cell apoptosis via mitochondrial death pathway. Circ Res. 2007 Nov 26;101(11):1113-22. doi: 10.1161/CIRCRESAHA.107.157644
  32. Chien KR, Hoshijima M. Unravelling Ras signals in cardiovascular disease. Nat Cell Biol. 2004 Sep;6(9):807-8. doi: 10.1038/ncb0904-807
  33. Kalinin RE, Suchkov IA, Pshennikov AS, Slepnev AA. Jeffektivnost L-arginina v lechenii ateroskleroza arterij nizhnih konechnostej i profilaktike restenoza zony rekonstrukcii. Vestn Ivan Med Akad. 2013;18(2):18-21. (In Russ.)
  34. Spiguel LR, Chandiwal A, Vosicky JE, Weichselbaum RR, Skelly CL. Concomitant proliferation and caspase-3 mediated apoptosis in response to low shear stress and balloon injury. J Surg Res. 2010 Jun 1;161(1):146-55. doi: 10.1016/j.jss.2008.11.001
  35. Kamenz J, Seibold W, Wohlfrom M, Hanke S, Heise N, Lenz C, Hanke H. Incidence of intimal proliferation and apoptosis following balloon angioplasty in an atherosclerotic rabbit model. Cardiovasc Res. 2000 Feb;45(3):766-76. doi: 10.1016/s0008-6363(99)00355-7
  36. Huang J, Yin H, Leng J, Yao Y, Yao R, Peng T, Li J. Evidence of apoptotic smooth muscle cells in proliferative intima of injured arteries. Chin Med J (Engl). 2000 Jan;113(1):10-13. doi: 10.3760/cma.j.issn.0366-6999.2000.01.103
  37. Perlman H, Maillard L, Krasinski K, Walsh K. Evidence for the rapid onset of apoptosis in medial smooth muscle cells after balloon injury. Circulation. 1997;95(4):981-87. doi: 10.1161/01.cir.95.4.981
  38. Bauriedel G, Schluckebier S, Hutter R, Welsch U, Kandolf R, Lüderitz B, Prescott MF. Apoptosis in restenosis versus stable-angina atherosclerosis: implications for the pathogenesis of restenosis. Arterioscler Thromb Vasc Biol. 1998 Jul;18(7):1132-39. doi: 10.1161/01.atv.18.7.1132
  39. Isner JM, Kearney M, Bortman S, Passeri J. Apoptosis in human atherosclerosis and restenosis. Circulation. 1995 Jun 1;91(11):2703-11. doi: 10.1161/01.cir.91.11.2703
  40. Durand E, Mallat Z, Addad F, Vilde F, Desnos M, Guérot C, Tedgui A, Lafont A. Time courses of apoptosis and cell proliferation and their relationship to arterial remodeling and restenosis after angioplasty in an atherosclerotic rabbit model. J Am Coll Cardiol. 2002 May 15;39(10):1680-85. doi: 10.1016/s0735-1097(02)01831-4
  41. Hassan AH, Lang IM, Ignatescu M, Ullrich R, Bonderman D, Wexberg P, Weidinger F, Glogar HD. Increased intimal apoptosis in coronary atherosclerotic vessel segments lacking compensatory enlargement. J Am Coll Cardiol. 2001 Nov 1;38(5):1333-39. doi: 10.1016/s0735-1097(01)01569-8
  42. Duran X, Vilahur G, Badimon L. Exogenous in vivo NO-donor treatment preserves p53 levels and protects vascular cells from apoptosis. Atherosclerosis. 2009 Jul;205(1):101-6. doi: 10.1016/j.atherosclerosis.2008.11.016
  43. Toumpoulis IK, Malamou-Mitsi VD, Michalis LK, Katsouras , Gloustianou G, Galaris D, Bai M, Vardakas D, Agnantis N, Sideris DA. Apoptosis bcl-2 and nitrotyrosine expression in an angioplasty-restenosis rabbit: an experimental model. Int J Surg. 2007;5(4):260-66. doi: 10.1016/j.ijsu.2007.01.003
  44. Spiguel LR, Chandiwal A, Vosicky JE, Weichselbaum RR, Skelly CL. Concomitant proliferation and caspase-3 mediated apoptosis in response to low shear stress and balloon injury. J Surg Res. 2010 Jun 1;161(1):146-55. doi: 10.1016/j.jss.2008.11.001
  45. Shibata R, Kai H, Seki Y, Kato S, Wada Y, Hanakawa Y, Hashimoto K, Yoshimura A, Imaizumi T. Inhibition of STAT3 prevents neointima formation by inhibiting proliferation and promoting apoptosis of neointimal smooth muscle cells. Hum Gene Ther. 2003 May 1;14(7):601-10. doi: 10.1089/104303403321618128
  46. Zhao Z, Huang C, Wang J, Jiang H, Li J, Wang X. Effect of arsenic trioxide on inhibition of restenosis after rabbit vascular injury and its mechanism. Chin Med J (Engl). 2002 Nov;115(11):1608-14.
  47. Pshennikov AS, Deev RV. Morphological illustration of alterations in the arterial endothelium in ischemic and reperfusion injuries. Ros Med-Biol Vestn im Akad IP Pavlova. 2018;26(2):184-94. doi: 10.23888/PAVLOVJ2018262184-194 (In Russ.)
  48. Walensky LD. BCL-2 in the crosshairs: tipping the balance of life and death. Cell Death Differ. 2006 Aug;13(8):1339-50. doi: 10.1038/sj.cdd.4401992
  49. Shpakova VS, Gambaryan SP, Rukoyatkina NI, Krivchenko AI. High-affinity inhibitor of bcl-xl protein activates protein kinase a in platelets and blocks their activation. Ros Fiziol Zhurn im IM Sechenova. 2018;104(9):1106-15. doi: 10.7868/S0869813918090095 (In Russ.)
Address for correspondence:
390026, Russian Federation, Ryazan,
Vysokovoltnaya str. 9,
Ryazan State Medical University,
the Department of Cardiovascular,
Endovascular, Operative Surgery
and Topographic Anatomy
tel. +7 4912 46-08-03,
Suchkov Igor A.
Information about the authors:
Kalinin Roman E., MD, Professor, Rector, Head of the Department of Cardiovascular, Endovascular, Operative Surgery and Topographic Anatomy, Ryazan State Medical University, Ryazan, Russian Federation.
Suchkov Igor A., MD, Professor, Vice-Rector for Research and Innovative Development, Professor of the Departmentr of Cardiovascular, Endovascular, Operative Surgery And Topographic Anatomy, Ryazan State Medical University, Ryazan, Russian Federation.
Klimentova mma A., Post-Graduate Student of the Department of Cardiovascular, Endovascular, Operative Surgery and Topographic Anatomy, Ryazan State Medical University, Ryazan, Russian Federation.
Egorov Andrei A., PhD, Associate Professor of the Departmentr of cardiovascular, endovascular, operative surgery and topographic anatomy, Ryazan State Medical University, Ryazan, Russian Federation.
Contacts | ©Vitebsk State Medical University, 2007-2023